Zentalis Pharmaceuticals, Inc. Common Stock

ZNTLNASDAQ • USD
1.49 USD
↘ 0.11 (6.75%)🟢LIVE (AS OF 02:26 PM EST)
🟢Market: OPEN

Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) is currently trading at $1.49. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 16, 2026.

Open?$1.60
High?$1.68
Low?$1.49
Prev. Close?$1.60
Volume?874.6K
Avg. Volume?1.3M
VWAP?$1.51
Rel. Volume?0.66x
Bid / Ask
Bid?$1.48 × 900
Ask?$1.49 × 800
Spread?$0.01
Midpoint?$1.48
Valuation & Ratios
Market Cap?157.2M
Shares Out?98.3M
Float?65.4M
Float %?69.1%
P/E Ratio?N/A
P/B Ratio?0.77
EPS?-$1.44
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Employees
106
Market Cap
167.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-04-03
Address
10275 SCIENCE CENTER DRIVE
SAN DIEGO, CA 92121
Phone: (858) 263-4333
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
23
Short Sent.?
70
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.21Distress
Confidence?47%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?7.70%Elevated
Short Interest?5.0M
Days to Cover?3.5
Free Float65.4M
Avg Daily Volume1.4M
Settlement Date2026-10-30
Financial Health
Current Ratio?7.33Strong
Quick Ratio?7.33Strong
Cash Ratio?0.74Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.77CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.9CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-69.1%WEAK▾
ROA?
S&P
3
-52.4%WEAK▾
Cash Flow & Enterprise
FCF?$-133873000
Enterprise Value?$133.2M
Fundamentals ratios updated end of day